Stewart Sherri L, Townsend Julie S, Puckett Mary C, Rim Sun Hee
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention , Atlanta, Georgia .
J Womens Health (Larchmt). 2016 Mar;25(3):235-41. doi: 10.1089/jwh.2015.5735.
Ovarian cancer is the deadliest gynecologic cancer. Receipt of treatment from a gynecologic oncologist is an evidence-based recommendation to reduce mortality from the disease. We examined knowledge and application of this evidence-based recommendation in primary care physicians as part of CDC gynecologic cancer awareness campaign efforts and discussed results in the context of CDC National Comprehensive Cancer Control Program (NCCCP). We analyzed primary care physician responses to questions about how often they refer patients diagnosed with ovarian cancer to gynecologic oncologists, and reasons for lack of referral. We also analyzed these physicians' knowledge of tests to help determine whether a gynecologic oncologist is needed for a planned surgery. The survey response rate was 52.2%. A total of 84% of primary care physicians (87% of family/general practitioners, 81% of internists and obstetrician/gynecologists) said they always referred patients to gynecologic oncologists for treatment. Common reasons for not always referring were patient preference or lack of gynecologic oncologists in the practice area. A total of 23% of primary care physicians had heard of the OVA1 test, which helps to determine whether gynecologic oncologist referral is needed. Although referral rates reported here are high, it is not clear whether ovarian cancer patients are actually seeing gynecologic oncologists for care. The NCCCP is undertaking several efforts to assist with this, including education of the recommendation among women and providers and assistance with treatment summaries and patient navigation toward appropriate treatment. Expansion of these efforts to all populations may help improve adherence to recommendations and reduce ovarian cancer mortality.
卵巢癌是最致命的妇科癌症。由妇科肿瘤学家进行治疗是一项基于证据的建议,旨在降低该疾病的死亡率。作为美国疾病控制与预防中心(CDC)妇科癌症宣传活动的一部分,我们调查了初级保健医生对这一基于证据的建议的了解和应用情况,并在CDC国家综合癌症控制计划(NCCCP)的背景下讨论了结果。我们分析了初级保健医生对关于他们将被诊断为卵巢癌的患者转诊给妇科肿瘤学家的频率以及未转诊原因问题的回答。我们还分析了这些医生对有助于确定计划手术是否需要妇科肿瘤学家的检查的了解情况。调查回复率为52.2%。共有84%的初级保健医生(87%的家庭/全科医生、81%的内科医生以及妇产科医生)表示他们总是将患者转诊给妇科肿瘤学家进行治疗。不总是转诊的常见原因是患者的偏好或执业地区缺乏妇科肿瘤学家。共有23%的初级保健医生听说过OVA1检测,该检测有助于确定是否需要转诊至妇科肿瘤学家。尽管此处报告的转诊率很高,但尚不清楚卵巢癌患者是否实际在看妇科肿瘤学家进行治疗。NCCCP正在开展多项工作来协助解决这一问题,包括在女性和医疗服务提供者中开展该建议的教育,以及在治疗总结和引导患者接受适当治疗方面提供帮助。将这些工作扩展到所有人群可能有助于提高对建议的依从性并降低卵巢癌死亡率。